By
Latest Stories
Don’t miss our hot and upcoming stories
GSK Expands AI Capabilities with $70 Million Tempus Partnership
London, UK – October 18, 2022 GSK has entered into a $70 million agreement with…
Eli Lilly and Genesis AI Announce $670M AI-Driven Drug Discovery Partnership
BURLINGAME, California – May 3, 2022 Harnessing AI to Unlock Breakthrough Therapies Eli Lilly and…
Genesis AI and Genentech (Roche) Form Multi-Target AI Drug Discovery Partnership
BURLINGAME, California – Oct 19, 2020 Genesis Therapeutics, a pioneer in AI-driven drug discovery, has…